Tags: GILD

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 70.65 today, indicating a change of 0.24%. Gilead Sciences, Inc. has a market capitalization of 93.09 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 67.5 today, indicating a change of 2.91%. Gilead Sciences, Inc. has a market capitalization of 89.15 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 65.59 today, indicating a change of 1.19%. Gilead Sciences, Inc. has a market capitalization of 86.63 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

With its market value over its outstanding shares, Gilead Sciences, Inc. (NASDAQ:GILD) Biotechnology has a market capitalization valued at Biotechnology. As the outstanding stock of Gilead Sciences, Inc. NASDAQ:GILD Biotechnology is bought and sold in the stock market, the current market cap indicates the existing public opinion of the net worth of Gilead Sciences, Inc. GILD Biotechnology. The existing figure surely determines…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 64.12 today, indicating a change of -1.06%. Gilead Sciences, Inc. has a market capitalization of 84.69 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 64.81 today, indicating a change of 0.00%. Gilead Sciences, Inc. has a market capitalization of 84.95 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 64.99 today, indicating a change of -0.25%. Gilead Sciences, Inc. has a market capitalization of 85.19 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Brief Overview Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been performing well. Gilead Sciences, Inc. reported a price of 64.78 today, indicating a change of -0.57%. Gilead Sciences, Inc. has a market capitalization of 85.4 B, with a return on assets (ROA) of 22.80% and an earnings per share (EPS) of 9.46 for the…

Outlined as the total market value of all unsettled shares of the company, the current market cap for the Gilead Sciences, Inc. (NASDAQ:GILD) Biotechnology is valued at 85.77 B. The dominant statistics will authorize the investment community to govern the size of Gilead Sciences, Inc. compared to the sales or total assets figures. Consequently, investors will be able…

Summary of Gilead Sciences, Inc. (GILD) | Monday May 8, 2017 Gilead Sciences, Inc. (NASDAQ:GILD), from Healthcare sector has been on the upside of the performance spectrum. Gilead Sciences, Inc. stated a price of 67.32 today, indicating a positive change of -0.71%. Gilead Sciences, Inc. is operating with a market capitalization of 88.68B, with a return on assets (ROA)…